If not now, when? It’s a question would-be NeuroMetrix (NASDAQ:NURO) investors might be asking themselves. More aptly and as it relates to the performance of NURO stock, if not then, then or then, it’s likely fair warning to find another game that’s finished. Let me explain. Source: Shutterstock It’s a reasonable inquiry. That is, an…

There is a very sound bull thesis building around NeuroMetrix (NASDAQ:NURO) stock following its price spike last month.  Source: shutterstock.com/MAD.vertise There’s quite a lot to like about the tiny Massachusetts company that’s developing three commercial products, the most notable of which is Quell. The latter product is a wearable device which treats lower extremity pain…

For months and even years, medical-device innovator NeuroMetrix (NASDAQ:NURO) stayed largely under financial traders’ radars. In 2021, however, plenty of investors are aware of NURO stock. Source: Shutterstock To understand why, we only need to look at the stock’s wild price movements over the past month. Well-timed traders have made a killing, but the biggest…

Bitcoin (CCC:BTC-USD) mining stocks are all soaring today as investors are excited about a BTC conference taking place today. Source: Shutterstock The Bitcoin conference today is called “The B Word” and it has a subhead of “How Institutions Can Embrace Bitcoin”. News of the conference has spread and the hashtag “#TheBWord” is now trending on…

Today is a very surprising one for those holding NeuroMetrix (NASDAQ:NURO) stock. Yesterday saw huge news coming from the biotech outfit, which catalyzed huge gains. And today, those gains are recurring. Things are quiet out of the NeuroMetrix camp today, and yet, the stock is seeing gains equal to those resulting from yesterday’s announcement. What’s the…

Robinhood is holding a roadshow this weekend to go over details of the company’s upcoming initial public offering (IPO). Source: mundissima / Shutterstock.com The Robinhood IPO Roadshow is set to take place on July 24 from 3:00 p.m. Eastern time to 4:00 p.m. Eastern Time and will feature a livestream hosted by CEO Vlad Tenev…

NeuroMetrix (NASDAQ:NURO) stock is surging higher on Tuesday after getting “Breakthrough Device Designation” from the U.S. Food and Drug Administration (FDA). Source: Shutterstock The breakthrough designation is for NeuroMetrix’s Quell device designed to treat symptoms in adult patients suffering from fibromyalgia. This is due to the unmet need for managing pain from fibromyalgia without pharmacological…